Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
4
×
deals
4
×
life sciences
4
×
national blog main
4
×
san francisco blog main
boston blog main
fda
national top stories
new york blog main
akouos
cancer
clinical trials
ipo
new york top stories
san diego blog main
san diego top stories
san francisco top stories
startups
venture capital
abbvie
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
ashley mcevoy
astellas pharmaceuticals
astrazeneca
auris health
autoimmune
avalon ventures
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer immunotherapy
What
plans
4
×
ipo
deal
medicines
acquiring
acquisitions
advance
affects
americans
announced
approved
auris
billion
bio
biology
builds
buy
cash
ceo
collabs
company
company’s
covid
cytokine
daniel
date
developer
developing
drug
drugs
enhanced
fda
files
frequency
gilead
gilead’s
health
hearing
help
initial
Language
unset
Current search:
plans
×
biotech
×
photo
×
" life sciences "
×
deals
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs